GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dai Han Pharmaceutical Co Ltd (XKRX:023910) » Definitions » E10

Dai Han Pharmaceutical Co (XKRX:023910) E10 : ₩0.00 (As of Sep. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Dai Han Pharmaceutical Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Dai Han Pharmaceutical Co's adjusted earnings per share data for the three months ended in Sep. 2024 was . Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₩0.00 for the trailing ten years ended in Sep. 2024.

During the past 12 months, Dai Han Pharmaceutical Co's average E10 Growth Rate was -100.00% per year. During the past 3 years, the average E10 Growth Rate was 13.50% per year. During the past 5 years, the average E10 Growth Rate was 14.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Dai Han Pharmaceutical Co was 29.90% per year. The lowest was 12.80% per year. And the median was 15.70% per year.

As of today (2024-12-11), Dai Han Pharmaceutical Co's current stock price is ₩26550.00. Dai Han Pharmaceutical Co's E10 for the quarter that ended in Sep. 2024 was ₩0.00. Dai Han Pharmaceutical Co's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Dai Han Pharmaceutical Co was 31.70. The lowest was 6.71. And the median was 11.64.


Dai Han Pharmaceutical Co E10 Historical Data

The historical data trend for Dai Han Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dai Han Pharmaceutical Co E10 Chart

Dai Han Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,503.52 2,761.53 3,159.28 3,595.77 4,038.98

Dai Han Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,973.45 4,038.98 4,114.68 - -

Competitive Comparison of Dai Han Pharmaceutical Co's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Dai Han Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dai Han Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dai Han Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Dai Han Pharmaceutical Co's Shiller PE Ratio falls into.



Dai Han Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Dai Han Pharmaceutical Co's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=1443/*
=

Current CPI (Sep. 2024) = .

Dai Han Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201412 285.000 99.098 0.000
201503 442.000 99.720 0.000
201506 635.000 100.050 0.000
201509 684.000 100.110 0.000
201512 535.000 100.220 0.000
201603 693.000 100.560 0.000
201606 716.000 100.790 0.000
201609 864.000 101.460 0.000
201612 669.000 101.560 0.000
201703 897.000 102.850 0.000
201706 1,100.000 102.610 0.000
201709 1,284.000 103.490 0.000
201712 858.000 102.990 0.000
201803 1,117.000 104.100 0.000
201806 1,316.000 104.130 0.000
201809 1,148.000 105.650 0.000
201812 1,172.000 104.350 0.000
201903 1,073.000 104.490 0.000
201906 1,210.000 104.880 0.000
201909 1,113.000 105.200 0.000
201912 1,298.000 105.120 0.000
202003 1,162.000 105.540 0.000
202006 833.000 104.870 0.000
202009 1,081.000 106.200 0.000
202012 -179.000 105.765 0.000
202103 860.000 107.357 0.000
202106 933.000 107.579 0.000
202109 1,166.000 108.759 0.000
202112 819.000 109.676 0.000
202203 1,030.000 111.806 0.000
202206 1,156.000 114.083 0.000
202209 1,361.000 114.831 0.000
202212 624.000 115.200 0.000
202303 1,243.000 116.550 0.000
202306 1,253.000 117.140 0.000
202309 1,336.000 119.111 0.000
202312 1,002.000 118.848 0.000
202403 1,406.000 118.848 0.000
202406 1,364.000 0.000
202409 1,443.000 0.000

Add all the adjusted EPS together and divide 10 will get our e10.


Dai Han Pharmaceutical Co  (XKRX:023910) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Dai Han Pharmaceutical Co was 31.70. The lowest was 6.71. And the median was 11.64.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Dai Han Pharmaceutical Co E10 Related Terms

Thank you for viewing the detailed overview of Dai Han Pharmaceutical Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Dai Han Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
8-3, 4-Ga Yangpyeong-dong, Yeongdeungpo-gu, Seoul, KOR
Dai Han Pharmaceutical Co Ltd is a South Korea based company engages in the manufacture, supply, and distribution of pharmaceutical products such as infusions, injections, drugs used in contrast media, drugs used for external uses and quasi-drugs.

Dai Han Pharmaceutical Co Headlines

No Headlines